Artelon

Marietta, United States Founded: 1986 • Age: 40 yrs Acquired By Stryker
Regenerative biomaterials for tendon and ligament reconstruction are developed.
Request Access

About Artelon

Artelon is a company based in Marietta (United States) founded in 1986 by Lars Peterson was acquired by Stryker in June 2024.. Artelon has raised $20 million across 1 funding round from investors including Stryker and Vensana Capital. Artelon offers products and services including FLEXBAND. Artelon operates in a competitive market with competitors including Theradaptive, Aziyo Biologics, MiMedx Group, Ossio and RevBio, among others.

  • Headquarter Marietta, United States
  • Founders Lars Peterson
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $20 M (USD)

    in 1 rounds

  • Latest Funding Round
    $20 M (USD), Series B

    May 24, 2023

  • Investors
    Stryker

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Stryker

    (Jun 03, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Artelon

Artelon offers a comprehensive portfolio of products and services, including FLEXBAND. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Enhances strength of repaired tissues for ankle stability.

People of Artelon
Headcount 1-10
Employee Profiles 7
Employee Profiles
People
Tara Aycock Newton
Controller
People
Eugenio Ferrario
Senior Process Development Engineer
People
Chris Dellelo
Area Sales Director - Boston
People
Todd Goede
EVP Innovation And Manufacturing

Unlock access to complete

Funding Insights of Artelon

Artelon has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series B round of $20 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series B — $20.0M
  • First Round

    (24 May 2023)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2023 Amount Series B - Artelon Valuation Vensana Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Artelon

Artelon has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Stryker and Vensana Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments in medical technology are made by Vensana Capital.
Founded Year Domain Location
3D-printed orthopedic products are manufactured for medical applications.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Artelon

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Artelon

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Artelon Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Artelon

Artelon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theradaptive, Aziyo Biologics, MiMedx Group, Ossio and RevBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutic delivery platform is developed for orthopedic clinical indications.
domain founded_year HQ Location
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
domain founded_year HQ Location
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
domain founded_year HQ Location
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
domain founded_year HQ Location
Synthetic adhesives for bone and dental repair are developed.
domain founded_year HQ Location
Developer of stem cells to regrow damaged bones
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Artelon

When was Artelon founded?

Artelon was founded in 1986 and raised its 1st funding round 37 years after it was founded.

Where is Artelon located?

Artelon is headquartered in Marietta, United States. It is registered at Marietta, Georgia, United States.

Who is the current CEO of Artelon?

Aaron Smith is the current CEO of Artelon.

Is Artelon a funded company?

Artelon is a funded company, having raised a total of $20M across 1 funding round to date. The company's 1st funding round was a Series B of $20M, raised on May 24, 2023.

What does Artelon do?

Artelon was founded in 1986 and is headquartered in Marietta, United States. Biomaterials are developed by the company for regenerative medicine, targeting soft tissue reconstruction in tendons and ligaments. Solutions are provided for pain management, functional restoration, arthritis treatment, and deformity correction. Elasticity is enhanced in healing tissues to support natural motion, within the medical devices and biotechnology sector.

Who are the top competitors of Artelon?

Artelon's top competitors include EpiBone, Theradaptive and MiMedx Group.

What products or services does Artelon offer?

Artelon offers FLEXBAND.

Who are Artelon's investors?

Artelon has 2 investors. Key investors include Stryker, and Vensana Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available